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Deposition of Burkholderia pseudomallei within either the lungs or nasal passages of the
Balb/c murine model resulted in different infection kinetics. The infection resulting from the
inhalation of B. pseudomallei within a 12μm particle aerosol was prolonged compared to a
1μm particle aerosol with a mean time-to-death (MTD) of 174.7 ± 14.9 h and 73.8 ± 11.3 h,
respectively. Inhalation of B. pseudomallei within 1μm or 12μm particle aerosols resulted
in a median lethal dose (MLD) of 4 and 12 cfu, respectively. The 12μm particle inhalational
infection was characterized by a marked involvement of the nasal mucosa and extension
of bacterial colonization and inflammatory lesions from the olfactory epithelium through
the olfactory nerves (or tracts) to the olfactory bulb (100%), culminating in abscessation
of the brain (33%). Initial involvement of the upper respiratory tract lymphoid tissues
(nasal-associated lymphoid tissue (NALT) and cervical lymph nodes) was observed in
both the 1 and 12μm particle inhalational infections (80–85%). Necrotising alveolitis and
bronchiolitis were evident in both inhalational infections, however, lung pathology was
greater after inhalation of the 1μm particle aerosol with pronounced involvement of the
mediastinal lymph node (50%). Terminal disease was characterized by bacteraemia in
both inhalational infections with dissemination to the spleen, liver, kidneys, and thymus.
Treatment with co-trimoxazole was more effective than treatment with doxycycline
irrespective of the size of the particles inhaled. Doxycycline was more effective against
the 12μm particle inhalational infection as evidenced by increased time to death. However,
both treatment regimes exhibited significant relapse when therapy was discontinued with
massive enlargement and abscessation of the lungs, spleen, and cervical lymph nodes
observed.
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INTRODUCTION
Burkholderia pseudomallei, the causative agent of melioido-
sis in humans is endemic to Southeast Asia and northern
Australia. A range of potentially fatal presentations can occur
ranging from chronic to acute and sub-acute disease with sec-
ondary pneumonia due to haematogenous seeding a common
manifestation. However, primary pneumonia can also develop
through direct inhalation of airborne bacteria (Gilad, 2007;
Limmathurotsakul and Peacock, 2011). This can be evidenced
by the association of pneumonic infection with heavy rain-
falls in Australia and the exposure of soldiers to contaminated
dust aerosolized by the action of helicopter rotors in Vietnam
(Howe et al., 1971; Currie and Jacups, 2003; Cheng et al., 2006,
2008).
Aerosol particle size affects where micro-organisms deposit
within the continuum of the respiratory tract. Furthermore, it
has been demonstrated for a number of pathogens in a range
of animal infection models that aerosol particle size influences
pathogenesis (Druett et al., 1953, 1956a,b; Day and Berendt,
1972; Thomas et al., 2010). The pneumonic inhalational model
of melioidosis has been extensively studied in murine models
(Jeddeloh et al., 2003; Tan et al., 2008; Titball et al., 2008; Lever
et al., 2009). Recently, the first non-human primate model has
been published based on the marmoset (Nelson et al., 2011).
Evidence for differential pathology resulting from deposition of
B. pseudomallei within the upper respiratory tract was provided
by the study of Owen et al. (2009) where bacteria instilled through
the nasal cavity colonized and replicated within the nasal cavity
and nasal-associated lymphoid tissue (NALT). Infection of the
olfactory epithelium and brain was observed prior to detection
of the bacteria within the bloodstream indicating an alterna-
tive route of entry into the brain as opposed to haematogenous
dissemination.
Melioidosis is difficult to treat due to the intrinsic resistance
of the bacterium to antibiotics, partly due to occupation of an
intracellular niche and partly due to the possession of a range
of resistance mechanisms including efflux pumps, degradative
enzymes, and mutational changes in antibiotic targets (Moore
et al., 1999; Tribuddharat et al., 2003; Mima and Schweizer, 2010).
Abscessation adds complexity as antibiotics experience difficul-
ties reaching minimum inhibitory concentrations for clinically
relevant periods of time (Wagner et al., 2006).
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This study determined the influence of aerosol particle size on
the pathogenesis of inhalationalmelioidosis in a murine infection
model and assessed the efficacy of antimicrobial chemotherapy
against the resultant infections.
MATERIALS AND METHODS
ANIMAL CARE
Female Balb/c mice (Charles River, UK) were housed with access
to food and water ad libitum at ACDP (Advisory Committee on
Dangerous Pathogens) biological safety level (BSL)-3. Procedures
were performed in accordance with the Scientific Procedures
(Animals) Act 1986 and the Codes of Practice for the Housing
and Care of Animals Used in Scientific Procedures, 1989. All mice
were 6–8 weeks old and weighing 20–25 g upon commencement
of aerosol exposures.
PREPARATION OF B. pseudomallei K96243 FOR AEROSOL CHALLENGE
B. pseudomallei was obtained from the Defence Science and
Technology Laboratory culture collection (Dstl Porton Down,
Salisbury, Wiltshire, UK). Stock cultures were maintained by
at −80◦C in nutrient broth containing 10% (vol/vol) glycerol.
Enumeration was routinely performed on Columbia Blood agar
plates at 37◦C for 24 h. For aerosol exposures, nutrient broth cul-
tures were shaken at 120 revolutions min−1 for 24 h at 37◦C.
The required dilutions were prepared in nutrient broth in 10ml
volumes immediately prior to challenge.
AEROSOL EXPOSURES
Groups of 10 mice were nose-only exposed for a period of 10min
to aerosols generated by the Collison nebuliser or flow-focusing
aerosol generator (FFAG) according to the methodology previ-
ously described (Thomas et al., 2008, 2009). Aerosol samples from
the challenges involving the Collison nebuliser were collected for
1min into an all-glass impinger (AGI-30; Ace Glass Inc., NJ) con-
taining 10ml of phosphate buffered saline (PBS) at a flow rate
of 12 l min−1. The impinger samples were serially diluted and
plated onto Columbia blood agar for enumeration. All exposures
were performed within a rigid unpolymerized polyvinylchloride
(PVCu) half-suit isolator at BSL-3. The mass median aerosol
diameters (MMAD) of the particles were 1–3μm and 12μm,
respectively, for the Collison nebuliser and the FFAG. The mean
calculated inhaled dose for small particles was determined using
the impinger data and Guyton’s formula (Guyton, 1947). The
actual mean inhaled dose for small or large particles was derived
from physical washing or dissection and homogenization of the
nasal passages, trachea, and lungs as described below.
DEPOSITION AND INFECTION KINETICS
At specific time-points, five mice were culled by intraperi-
toneal administration of 0.5ml sodium pentobarbital (0 h) or
halothane intoxication (remaining time-points) and lungs, medi-
astinal lymph node, Peyer’s patches, gastrointestinal lymph nodes
(mesenteric, jejunal, colonic), trachea, oesophagus, stomach,
intestine, liver, and kidneys aseptically collected. Blood was col-
lected by cardiac puncture after halothane anaesthetization into
heparin coated plasma tubes (BD Biosciences, UK). Bacteria
deposited in the nasal passages (nasal washings) were collected by
inserting a catheter (outer and inner diameter 1.02 and 0.58mm,
respectively; Harvard Apparatus) into a tracheal incision and
flushing with 1ml of PBS containing final concentrations of
1mM NaOH and 0.1% (v/v) Triton-X100. Tissue samples were
homogenized in PBS (Gibco®, Invitrogen Ltd., UK). All samples
were enumerated by serial dilution and plating of 100μl aliquots
in triplicate onto Columbia blood agar plates.
DETERMINATIONOF MEDIAN LETHAL DOSE (MLD)
Groups of 10 mice were exposed nose-only for 10min to
aerosolized B. pseudomallei K96243 at five different 10-fold dilu-
tions generated by either the Collison nebuliser or the FFAG
decreasing from the “neat” suspension of 109 cfu ml−1. Mice were
monitored for 21 d post-exposure for signs of infection. Mice
showing signs of infection were culled by cervical dislocation at
defined humane end-points. TheMLD was calculated by the 50%
end-point method (Reed and Muench, 1938), based on the num-
ber of bacteria retained in the lungs or nasal passages of animals
that received the neat suspension. Immediately after exposure,
five animals per dose were sacrificed for necropsy with removal of
the lungs, trachea, oesophagus, and stomach. The nasal passages
were washed as previously described. The number of bacteria
retained in the lungs or nasal passages was demonstrated to
decrease by one logarithm with each logarithmic dilution of the
spray suspension used in the dilution series.
HISTOPATHOLOGY
The mice were dissected to expose the abdominal and thoracic
cavities. The lungs were inflated by instillation of 1.5mL 10%
(v/v) neutral-buffered formalin (NBF) to provide a pressure of
25–30 cm3 H2O. The whole mouse was fixed in 10% (v/v) NBF
for 6 d with replacement with a fresh aliquot after 3 d. After a fur-
ther 3 d fixation, samples from a range of tissues including lungs
(apical, medium, and caudal lobes), lymph nodes (mediastinal,
submandibular/cervical, inguinal, and mesenteric nodes), nasal
cavity including NALT and turbinates, pharynx, trachea, thymus,
thyroid, eyes, brain (including olfactory bulb), oesophagus, stom-
ach, intestine, jejunum containing Peyer’s patches, spleen, liver,
kidneys, and sternal bone marrow were blocked and embed-
ded in paraffin wax. Serial 4μm thick sections were cut using
a Leica RM2025 microtome (Leica Microsystems Ltd., UK) and
dried onto charged slides at 37◦C overnight. Sections were stained
with haematoxylin and eosin or Gram Twort before examination
using a Leica DM4000B microscope. Images were taken using
a Leica DFC480 digital camera (Leica Microsystems Ltd., UK).
Lesions were scored on the basis of the number of animals dis-
playing specific pathological changes and the severity of these
lesions according to the system previously described (Thomas
et al., 2009).
EFFICACY OF ANTIMICROBIAL CHEMOTHERAPY
Groups of 10 mice challenged with either small or large par-
ticle aerosols (10 or 100MLDs) containing B. pseudomallei
K96243 were administered doxycycline or co-trimoxazole orally
for 14 days. Doxycycline oral suspension (Sigma-Aldrich, UK)
was administered to mice daily at 1mg/mouse (50mg/kg).
Co-trimoxazole oral suspension (Septrin®, Glaxo SmithKline
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Laboratories, UK) was administered to mice twice daily at
4.8mg/mouse (240mg/kg). Control groups of 10 infected, non-
treated mice were given sterile deionized water orally for 14 days.
All mice were observed twice daily for clinical signs of disease for
up to 96 days post-infection and mortality recorded. Doses were
derived from Food and Drugs Agency Guidance using inversed
scaling based on body weight (FDA, 2005).
STATISTICAL ANALYSIS
Data are expressed as the standard error (S.E) around the mean.
Tissues containing bacterial loads below the limit of detec-
tion (<10 cfu per organ) were designated culture-negative. Two-
sample t-test was used to test the significant differences in the
deposition data. The significant differences in the antibiotic stud-
ies was analysed by ANOVAs followed by Tukey’s honestly sig-
nificant difference post-test. P values of <0.05 are considered
significantly different.
RESULTS
Burkholderia pseudomallei CAN PRODUCE INFECTION AFTER
DEPOSITION IN THE URT
The regional deposition profiles of B. pseudomallei were deter-
mined to evaluate where the organisms would predominantly
deposit when inhaled within 1 or 12μm particles (Figure 1).
A culture containing 2.95 ± 0.35 × 109 cfu ml−1 of B. pseudo-
mallei was aerosolized and the retained dose determined. When
the 1μm particle aerosol was generated, impinger samples indi-
cated a retained bacterial dose of 2.79 × 105 cfu. The actual
retained dose determined at post-mortem was 1.40 ± 0.09 ×
105 cfu in lung tissues and 1.56 ± 0.77 × 103 cfu in the nasal pas-
sages. Hence, 87.7% and 1.0% of the total deposited fraction
were retained in the lungs and nasal passages, respectively; this
was a significant difference (p = 0.0002). When a 12μm parti-
cle aerosol was generated, 1.40 ± 0.22 × 105 and 9.50 ± 5.2 ×
103 cfu were recovered at post-mortem from the nasal passages
FIGURE 1 | Initial deposition of B. pseudomallei K96243 after exposure
to 1 or 12µm particle aerosols (shaded and open bars respectively);
values represent 30min post-exposure. Error bars represent the standard
errors (n = 10). Asterisks represent significant difference between particle
sizes.
and lungs, respectively. This was a significant difference, equiva-
lent to 87.6% and 6.0% of the total retained bacteria being present
within the nasal passages and lungs respectively (p = 0.0006).
The percentage of total deposited bacteria recovered from the
stomach was much reduced at 9.9% and 3.8% for mice that
inhaled the 1 or 12μm particles, respectively. The numbers of
bacteria present in the trachea and oesophagus was less than
2% of the total retained fraction irrespective of the size of par-
ticle inhaled. No significant differences were observed between
1 and 12μm particle aerosols for the numbers of B. pseudomallei
deposited in the trachea, oesophagus, and stomach (p > 0.09).
Ten-fold serial dilutions of the initial challenge culture resulted in
approximate 10-fold lower numbers deposited in the respiratory
tracts of mice (data not shown).
TheMLD of B. pseudomallei was determined to investigate the
number of bacteria required to generate infection in the URT
and LRT of mice challenged with 1 or 12μm particles Mice with
a retained dose of 103 cfu of 1μm particles displayed a MTD
of 52.8 ± 2.57 h, whilst a retained dose of 102 cfu resulted in
protracted infection with all of the mice succumbing by 22 d
post-infection with aMTD of 146.9 ± 37.5 h post-infection. Mice
with retained doses of 1 cfu resulted in 30% survival. When mice
received a retained dose of 3 × 103 cfu of B. pseudomallei in
12μm particles all of the animals died with a MTD of 91.9 ±
17.5 h whilst a retained dose of 30 cfu resulted in protracted infec-
tion with 90% of the mice succumbing by 21 d post-infection
with a MTD of 259.5 ± 33.6 h. Only 20% of mice that received
a retained dose of 3 cfu succumbed to infection. The mice that
survived until the end of the experiment had cleared the infec-
tion as evidenced by bacteriological analysis of lung and spleen
tissues. Irrespective of particle size, none of the mice challenged
with concentrations predicted to contain less than a single viable
bacterium died during the course of the experiment. Calculation
of the MLD produced values of 4 and 12 cfu, respectively for
B. pseudomallei in 1 or 12μm particles.
PATHOGENESIS OF INHALATIONALMELIOIDOSIS DIFFERS
DEPENDING ON THE SITE OF DEPOSITION
The temporal progression of inhalational melioidosis caused by
deposition of B. pseudomallei within either the LRT or URT was
characterized by bacteriological and histopathological analysis;
summarized in Table 1. Inhalation of the aerosol produced by the
Collison nebuliser (1μm particles) resulted in the deposition of
2.93 ± 0.3 × 102 and 1.6 ± 0.1 × 101 cfu in the lungs and nasal
passages, respectively. Conversely, the inhalation of the aerosol
produced by the FFAG (12μm particles) resulted in the deposi-
tion of 5.2 ± 4.1 × 101 and 3.0 ± 0.2 × 102 cfu in the lungs and
nasal passages, respectively. Irrespective of the aerosol genera-
tor used, the resultant infection was characterized by primary
pneumonic infection of the lung. Significant differences were
observed in the bacterial load in the lungs at 0 and 24 h post-
challenge (Figure 2; p = 0.034), however, by 96 h post-challenge
the loads were similar irrespective of the size of the particles
inhaled reaching 1.3–1.5 × 109 cfu g−1 (p = 0.96). Initially at
24 h post-challenge small inflammatory foci were observed with
neutrophilic exudates into the alveoli and necrosis indicative of
acute alveolitis that increased in size as the infection developed
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Table 1 | Comparative histopathological and bacteriological progression of inhalational melioidosis infections in the major tissues affected.
Particle size Tissuea Progression of infection post-challenge (h)b
24 48 72 96 120+c
Small particle aerosol (1–3μm) Nasal mucosa − − − + N.D
NALT − − − − N.D
Cervical node − + + + N.D
Mediastinal node − + ++ + + + N.D
Lung − ++ + + ++ + + + + + N.D
Pharynx/Trachea − + + ++ N.D
Olfactory epithelium − + + ++ N.D
Olfactory nerves/tracts − + + ++ N.D
Olfactory bulb − − − + N.D
Brain − − − − N.D
Spleen − + ++ + + + N.D
Liver − + ++ + + + N.D
Thymus − + + ++ N.D
Blood − + ++ + + ++ N.D
Large particle aerosol (12μm) Nasal mucosa + ++ ++ + + + + + + + +
NALT − + ++ ++ ++
Cervical node + ++ + + + + + + + + + + + + +
Mediastinal node − − + ++ ++
Lung − ++ + + + + + ++ + + ++
Pharynx/Trachea − + ++ + + + + + +
Olfactory epithelium ++ + + ++ + + + + + + + + + + + + + + +
Olfactory nerves/tracts − ++ + + + + + + + + + + + + +
Olfactory bulb − − ++ + + ++ + + + + +
Brain − − − ++ + + + +
Spleen − ++ + + + + + + + + + +
Liver − ++ + + + + + + + + + +
Thymus − + ++ + + + + + +
Blood − + + + + + + ++ N.D
ND, not determined.
aIntestine, stomach, Peyer’s patches, mesenteric lymph nodes, bone marrow, and oesophagus were negative for pathology until 96 h post-infection in both 1 and
12µm inhalational infections when bacteria were observed in the Peyer’s patches and mesenteric lymph nodes correlating with bacteraemia.
bSeverity of pathological changes and bacteriological load is scored subjectively according to the methods:−, none;+, mild;++, moderate;+ + +, marked;+ + ++,
major; + + + + +, severe.
cSome mice developed chronic infection and survived for up to 20d post-challenge.
(Figure 3). The foci were present throughout the cranial, middle
and caudal lobes. Inflammatory exudates were observed occupy-
ing bronchiolar airways by 72 h post-challenge (Figure 3C). In the
majority of mice that inhaled both 1μm (100%; 8/8) or 12μm
particles (82%; 14/17) the inflammatory foci merged into large
areas of consolidation comprising predominantly neutrophils
and fewer macrophages, bacterial colonies, and necrotic tissue
(Figure 3D). Most mice succumbed to infection by 72–120 h,
however, some survived for prolonged periods of up to 21 d post-
challenge. Interestingly at this stage, the lungs were almost com-
pletely consolidated (Figures 3E,F), however, surprisingly there
were no obvious signs of severe respiratory distress other than the
mice demonstrating clinical signs of ruffled fur and a hunched
posture.
However, differences were observed in the degree of URT and
neurological involvement between the infections. Differences in
the bacterial load within the nasal cavity were observed over
the time-course of experimentation with significance at 24 h
post-challenge (p = 0.009; Figure 2). Bacterial loads in the nasal
cavity increased reaching 1.3 ± 0.5 × 104 and 7.1 ± 4.1 × 105 cfu
ml−1 at 72 h post-challenge in mice that inhaled 1 and 12μm
particles, respectively (p = 0.073). By 48 h post-challenge, sig-
nificant pathological changes of epithelium of the nasal mucosa
was observed in mice exposed to B. pseudomallei with 12μm
aerosol particles. The olfactory epithelium was preferentially tar-
geted with 82% (14/17) of the mice demonstrating infection in
this region compared to the respiratory mucosa of the nasal cavity
(71%; 12/17). As early as 24 h post-challenge, neutrophil infiltra-
tion of the lamina propria and exudation in the nasal passages
with associated bacteria can be observed (Figure 4A).
NALT was preferentially infected in mice that inhaled B. pseu-
domallei within 12μm particles (41%; 7/17) compared to 1μm
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FIGURE 2 | Bacteriological kinetics within tissues of Balb/c mice
exposed to aerosols of different particle sizes containing Burkholderia
pseudomallei K96243. •, Small particle (1μm) infection generated by the
Collison nebuliser; ◦, large particle (12μm) infection generated by the FFAG.
Mean values are indicated by the solid and dotted lines for the small particle
and large particle infections respectively (n = 5). Significant differences
between the tissue loads are indicated by ∗(p < 0.05) and ∗∗(p < 0.01),
respectively.
particles (12.5%; 1/8) with lymphocytic degeneration and necro-
sis, neutrophilic infiltration and large numbers of bacteria present
within the necrotic tissue (Figure 4B). Interestingly, those mice
that survived past 120 h infection and subjected to histological
analysis did not show evidence of NALT involvement (0%; 0/3).
Irrespective of the size of the particles inhaled, the pharynx and
trachea were infected similarly at 75% (6/8) and 80% (12/15) for
mice that inhaled B. pseudomallei within 1 and 12μm particle
aerosols, respectively. In the pharynx, exudation into the luminal
space of sloughed epithelial cells was observed in 6–12% of mice.
An ulcerative and suppurative tracheitis occurred in 75–80% of
mice with sloughing of epithelial cells across extensive areas,
neutrophil infiltration, and exudation into the tracheal lumen
(Figure 4D). The severity of pharyngeal and tracheal pathology
appeared earlier and was more extensive in mice exposed to the
12μm particle aerosol (Table 1). In mice that inhaled 12μm
particles, the cervical lymph nodes became infected in 71% of
mice (12/17) by 24 h post-challenge. Pathological changes in the
cervical lymph nodes included multifocal necrosis, neutrophilic
infiltration, and granulomatic encapsulation by macrophages as
the early stages of abscessation (Figures 4E,F). In contrast, only
38% of mice (3/8) that inhaled B. pseudomallei within 1μm par-
ticles displayed similar histological changes in the cervical lymph
nodes.
In mice that inhaled 12μm particles, the inflammatory
response in the nasal cavity progressed over time, with exten-
sive neutrophilic infiltration and bacterial proliferation encom-
passing both the respiratory and olfactory epithelia observed at
96 h post-challenge (Figures 4C and 5A,B). Neutrophilic infil-
tration, bacterial infection, and inflammation of the olfactory
nerves/tract (80%; 12/15) and olfactory bulb (60%; 9/15) were
observed by 48–96 h post-challenge. Histological analysis indi-
cated neutrophilic infiltration into the axonal bundle of the
olfactory neurons followed by temporal passage into the olfactory
bulb (Figures 5C–E). Generally the infection was acute enough
for the mice to be humanely culled by 96–120 h post-challenge,
however, some mice survived for prolonged periods up to 20 d
post-challenge developing a chronic infection. In 33% of mice
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FIGURE 3 | Pathology of the lung after inhalation of B. pseudomallei K96243 aerosolized in 12µm aerosol particles. (A) 24h, (B) 48h, (C) 72h, (D) 96h,
(E) 9 d, and (F) 13 d. B, bronchiole, C, consolidated tissue, N, suppurative inflammation.
(2/6) that developed chronic infection (2/6) histological analy-
sis revealed infection of the olfactory tracts extending through
the ethmoidal foramina into the olfactory bulb of the brain.
Microabscesses were also observed in the medulla and brainstem
with the larger abscesses (∼0.5mm) located in the ventrorostral
and mid-regions of the brain (caudate putamen, olfactory areas)
(Figure 5F). Areas of suppurative encephalitis can be observed
with neutrophilic infiltration into the brain tissue. Infection of
the olfactory and respiratory epithelium was observed in mice
that inhaled 1μm particles containing B. pseudomallei, however,
comparatively this occurred later during the infection by 96 h and
to a lesser degree (37%; 3/8). Furthermore, only 12% of mice
(1/8) that inhaled 1μm particles demonstrated pathology of the
olfactory bulb.
Bacteraemia was observed at similar levels at 48 h post-
challenge in both inhalational infections, 0.57–1.4 × 102 cfu
ml−1 (p = 0.066) increasing to 1.3–2.2 × 105 cfu ml−1 by 96 h
post-challenge (p = 0.19; Figure 2). Bacteraemic and/or lym-
phatic spread to visceral organs such as the spleen and liver
was evident with hyperplasia in the red pulp, and multifocal
microabscess formation observed in both tissues as early as 48 h
post-challenge contributing at later time-points to spleno- and
hepatomegaly. In the spleen, the microabscesses merged into
larger abscesses at the later time-points (>96 h). The bacterial
loads in the spleen and liver were highly variable, particularly
at 96 h post-challenge, probably due to the degree of absces-
sation observed (Figure 2). For example at 96 h post-challenge,
although the spleen bacterial loads in the mice exposed to the
1μm particle aerosol was 5.85 ± 5.72 × 106 cfu g−1 and greater
than that observed in mice exposed to 12μm particle aerosols
(4.79 ± 7.37 × 105 cfu g−1), this was not a significant difference
due to the variance in loads observed between individual mice
(p = 0.46). The thymus was infected similarly in both the infec-
tions caused by the inhalation of 1 and 12μm particle aerosols
at 50% (4/8) and 53% (9/17), respectively, with lymphocytic
depletion and increased tangible body macrophages (Table 1).
Pathology in the inguinal lymph nodes was only observed at
96 h post-challenge in 12% (2/17) of mice that inhaled 12μm
particle aerosols. The mesenteric lymph nodes only displayed
pathological changes late in the infection in mice that inhaled
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FIGURE 4 | Upper respiratory tract pathology in mice that inhaled
12µm aerosol particles containing B. pseudomallei K96243.
(A) nasal epithelium, (B) NALT, (C) nasal respiratory epithelium,
(D) trachea, (E,F) cervical lymph nodes. L, lymphocyte,
N, suppurative inflammation, NE, nasal epithelium, OE, olfactory
epithelium.
12μm particles (29%; 5/17) displaying distension of the medulla
and/or subcapsular sinuses and marked medullary histiocytosis,
probably indicative of bacteraemic spread. No other gastrointesti-
nal pathology was observed irrespective of the size of particles
inhaled.
PROPHYLACTIC INTERVENTIONWITH CO-TRIMOXAZOLE AFFECTS
SURVIVAL IN THE LARGE PARTICLE INHALATIONAL INFECTION MODEL
Little published data exist on the in vivo efficacy of antimicrobials
against experimental melioidosis, particularly via inhalational
challenge. In human cases of melioidosis, prolonged combi-
natorial antimicrobial treatment is required with ceftazidime,
in conjunction with imipenem, co-trimoxazole, amoxicillin-
clavulanate, doxycycline, or chloramphenicol. However, doxycy-
cline (100mg twice daily) or co-trimoxazole (960mg twice daily)
are the prophylactic antibiotics of choice in a mass-casualty set-
ting resulting from an intentional release of B. pseudomallei and
hence the focus for this study (Chaowagul et al., 2005; Gilad
et al., 2007; HPA, 2008). A comparison was made between the
efficacy of doxycycline and co-trimoxazole to protect mice against
B. pseudomallei deposited in the respiratory tract within either
1 or 12μm particle aerosols (Figure 6). The MICs of doxycy-
cline and co-trimoxazole (trimethoprim/sulfamethoxazole) for
B. pseudomallei K96243 are 0.5 and 32/16μgml−1, respectively
(Barnes, pers. comm.). Mice were challenged with approxi-
mately 100 MLDs of B. pseudomallei within either 1 or 12μm
particle aerosols. The actual retained doses were 5.7 ± 1.1 ×
102 cfu and 8.7 ± 0.9 × 102 cfu for the 1 or 12μm parti-
cle aerosols within the lungs and nasal passages, respectively.
Irrespective of particle size, all of the untreated control mice
succumbed to the challenge. The MTD for the untreated con-
trol mice were significantly different at 2.5 ± 0 and 16.0 ± 5.2 d
for the 1 and 12μm particle aerosol infections, respectively
(p = 0.028).
Antimicrobial therapy was commenced, with a once or twice-
daily regimen of doxycycline (50mg kg−1) or co-trimoxazole
(240mg kg−1) at 12 h intervals for 14 d. Doxycycline was sig-
nificantly more effective against the 12μm particle infection
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FIGURE 5 | Olfactory and neurological pathology in mice that inhaled
B. pseudomallei K96243 in 12µm aerosol particles. (A,B) Olfactory
epithelium, (C,D) Olfactory nerves, (E) Olfactory bulb, (F) brain. A, abscess,
IB, infected olfactory bulb, IN, infected neurone, N, suppurative inflammation,
OB, olfactory bulb, NB, neuronal bundle. White arrows indicates direction of
neutrophil taxis and inflammation.
compared to the 1μm particle infection. Despite doxycycline
treatment, 90% ofmice that inhaled 1μmparticles succumbed by
26 d post-infection. Survival was increased to 69 d post-infection
in doxycycline treated mice that inhaled B. pseudomallei within
12μm particle aerosols. This was exemplified by significantly dif-
ferent MTDs for the 1 and 12μm particle infections at 13.0 ±
5.1 and 61.4 ± 1.5 d, respectively (p = 0.0001). Administration
of co-trimoxazole significantly prolonged survival with all of
the animals surviving until day 58 irrespective of the particle
size inhaled; however, clearance was not observed and the mice
started developing signs of infection 2–3 weeks after antimicro-
bial dosing was completed and began succumbing to infection
6–7 weeks post-infection. The experiment was terminated 93 d
post-infection with 0% and 20% survival observed in groups that
inhaled B. pseudomallei within 1 and 12μmparticles respectively.
TheMTDs for the 1 and 12μmparticle infections were 68.6 ± 4.5
and 88.0 ± 6.4 d, respectively (p = 0.0005). In all of the antibiotic
treated groups, bacteriological analysis of the lungs and spleens
indicated that clearance had not occurred. Bacterial burdens in
the lungs were significantly increased in mice treated with doxy-
cycline (1.1 ± 0.11 × 108 cfu g−1) compared to co-trimoxazole
treated mice (5.8 ± 2.4 × 104 cfu g−1; p = 0.007). No difference
was observed in bacterial loads from spleens irrespective of the
antibiotic treatment received with numbers ranging from 1.1 to
8.1 × 107 cfu g−1 (p = 0.14). Post-mortem analysis of mice in
groups that succumbed to infection 6–7 weeks post-treatment
indicated large abscesses present within the lungs, spleens and
often the cervical lymph nodes.
DISCUSSION
Increased incidence of inhalational melioidosis within endemic
countries in Southeast Asia and Northern Australia is associ-
ated with the monsoon season (Currie and Jacups, 2003; Cheng
et al., 2006, 2008). Exposure to airborne B. pseudomallei would
be predicted to increase in prevalence during the rains as bacteria
migrate through the soil, collect in puddles and are aerosolized
due to winds or human/animal activity into the humid atmo-
sphere. Clustered human and animal outbreaks of inhalational
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FIGURE 6 | Efficacy of antimicrobial chemotherapy with doxycycline or
co-trimoxazole against infection caused by the deposition of
B. pseudomallei K96243 within the lower or upper respiratory tract in
1 (closed symbols) or 12µm (open symbols) aerosol particles,
respectively. Circles, untreated control mice; squares, doxycycline treated
mice; triangles, co-trimoxazole treated mice.
melioidosis have been reported to be associated with heavy rain-
fall, localized flooding, gusting winds, and contamination of an
aerator unit in a water treatment plant (Ketterer et al., 1986;
Inglis et al., 1999, 2000). However, the particle size distribution
of the inhaled aerosols was unknown and a clear link between
particle size and pathology has not been established in such
incidences.
The data reported in this study indicates that aerosol particle
size can affect the infectivity and pathogenesis of B. pseudoma-
llei in the murine model. Despite clear differences in deposition
profiles between the LRT and URT, the infections produced by
the inhalation of B. pseudomallei within 1 and 12μm particle
aerosols had similarities particularly with respect to the tempo-
ral apparition and progression of pulmonary pathology. This can
be attributed to the fact that although predominantly comprising
larger particles, the aerosol generated by the FFAG, will also com-
prise some 1–3μm particles that would be predicted to deposit
in the lungs (Thomas et al., 2008). The low MLD of 4 cfu in
the Balb/c murine model of B. pseudomallei infection caused by
lung deposited 1μm particles means that it is impossible to gen-
erate purely LRT or URT infections on the basis of particle size
simply due to the dynamics of aerosol production and the kinet-
ics of aerosol deposition. However, this lack of a defined aerosol
generated by the FFAG is probably a more realistic reflection
of an environmental aerosol that will be naturally polydisperse.
The MLD of 4 cfu for B. pseudomallei K96243 contained within
1μmparticles is similar to the 5–20 cfu for B. pseudomallei strains
1026b, BRI NCTC 4845, 576, and KHW in the Balb/c murine
model (Jeddeloh et al., 2003; Tan et al., 2008; Titball et al., 2008;
Lever et al., 2009). Bacterial genetic background can influence
MLD as evidenced by the MLDs of 27 and 423 cfu reported for
B. pseudomallei strains 1026b and KHW in the C57BL/6 murine
strain (Jeddeloh et al., 2003; Tan et al., 2008). In addition the
temporal kinetics of infection for the 1μm particle inhalational
infection are similar to reports in the literature for various animal
models (murine, marmoset) with initial lung infection followed
by dissemination to visceral tissues once bacteraemia occurs at
approximately 24 h post-infection (Jeddeloh et al., 2003; Lever
et al., 2009; Nelson et al., 2011).
The MLD of 12 cfu obtained in this study with B. pseudoma-
llei within 12μmparticles is three-fold greater than that obtained
in mice that inhaled 1μm particles. Furthermore, the MTD was
significantly increased when the cumulative data from all experi-
ments was examined. MTDs of 73.8 ± 11.3 h and 174.7 ± 14.9 h
were obtained for mice that inhaled 1-5MLDs of B. pseudo-
mallei within 1 and 12μm particle aerosols respectively (n =
25, p = 0.007). Differences were observed as a result of deposi-
tion within the URT associated with increased pathology in the
nasal mucosa and associated lymphoid tissue and neural struc-
tures. Extensive ulceration of the nasal epithelium was observed
with preferential localization on the olfactory epithelium. An
acute suppurative neuritis ensued as bacteria and inflamma-
tory cells moved up the olfactory neuronal bundles into the
olfactory bulb via the ethmoidal foramina. The anterior and
posterior ethmoidal foramina are small gaps in the cribriform
plate of the skull through which the innervating neurons (and
blood vessels) of the nasal cavity directly pass into the brain.
This neurological path to the brain was independent of bacter-
aemic spread as the olfactory nerves were demonstrating signifi-
cant pathology at 24–48 h post-challenge when bacteraemia was
minimal. Interestingly, these pathological changes and bacterial
colonization has been observed after intranasal administration
of B. pseudomallei to Balb/c mice (Owen et al., 2009). In this
study, collation of all the murine data indicated that paraly-
sis was observed in 10/100 (10%) and 54/130 (42%) mice that
succumbed to infection after inhaling B. pseudomallei within
1 and 12μm particles, respectively (p = 0.0004). Paralysis is an
indicator of neurological dysfunction and this data highlight
the propensity of B. pseudomallei to infect neurological tissues
and that infection via deposition in the URT is a predisposing
factor.
B. pseudomallei can attach to human respiratory epithelial
cell lines through via attachment to gangliosides such as asialo-
GM1 and asialo-GM2 (Ahmed et al., 1999; Gori et al., 1999).
Indeed, attachment can be inhibited by incubation in the presence
of the disaccharide moieties (GalNAcβ1-4Gal and GalNAcβ1-
3Gal) present within the ganglioside structure (Thomas and
Brooks, 2004). The prevalence of these gangliosides increase on
the apical surface of damaged and repairing airway epithelial cells
(de Bentzmann et al., 1996). Increased damage to the nasal, olfac-
tory, pharyngeal, and tracheobronchial epithelia was observed
over the duration of the infection and increased expression of
binding ligands on the damaged cells may account for the preva-
lence of B. pseudomallei within these locations. Gangliosides,
including asialo-GM1 and asialo-GM2 are also prevalent on the
cell surface of neurones (Yu et al., 2011). The preference of
B. pseudomallei for the neurological pathway after deposition
in the URT may be due to its ability to bind to gangliosides
such as asialo-GM1 and asialo-GM2, and perhaps others as yet
unidentified.
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Direct infection of the brain via retrograde axonal trans-
port through the olfactory neurone from the nasal cavity has
been observed with viruses, bacteria, and protozoans including
Japanese encephalitis virus, Eastern equine encephalitis virus,
Venezuelan equine encephalitis virus, Influenza virus, Equine
herpesvirus-9, Streptococcus pneumoniae, Neisseria meningitidis,
Balamuthia mandrillaris and Naegleria fowleri (Danes et al.,
1973a,b,c; Martinez, 1977; Jarolim et al., 2000; van Ginkel et al.,
2003; Kiderlen and Laube, 2004; Roy et al., 2009; Yamada et al.,
2009; El-Habashi et al., 2010; Sjölinder and Jonsson, 2010; Steele
and Twenhafel, 2011; Schrauwen et al., 2012). Even prions have
been demonstrated to shed into the nasal cavity from the brain
using the reverse of this transport process (Corona et al., 2009;
Bessen et al., 2010). However, it is uncertain whether the olfactory
pathway as a route of infection extrapolates to NHPs and humans.
Indeed, the rodent olfactory epithelium has a much larger sur-
face area in comparison to primates (Harkema, 1991; Philström
et al., 2005). This perhaps predisposes rodents to infection via this
route.
Neurological melioidosis is an infrequent complication of
human infection presenting as encephalomyelitis in the pres-
ence or absence of multifocal abscessation (Lee and Chua, 1986;
Pelekanos and Appleton, 1988; Kasantikul et al., 1992; Woods
et al., 1992; Padiglione et al., 1998; Chadwick et al., 2002; Koszyca
et al., 2004). It is assumed that infection of the brain is a result
of bacteraemic spread; however, the olfactory neuronal pathway
has not been examined as a potential mechanism of infection via
the URT in primates. Interestingly, an association between sinusi-
tis in the frontal or maxillary sinuses of the URT and five cases
of cerebral melioidosis has been observed with the authors high-
lighting that the sinuses “may represent a source of entry into the
CNS” (Chadwick et al., 2002). One NHP study has been pub-
lished on B. pseudomallei infection in the marmoset resulting
from the inhalation of a small particle aerosol where no brain his-
tology was observed (Nelson et al., 2011). This is expected because
the 1–3μm particle aerosols generated deposit in the alveolar
region of the lung in the marmoset; however, it does not pre-
clude involvement of the olfactory neuronal pathway and brain
if deposition predominantly occurred within the nasal cavity.
Increased involvement of the URT lymphoid tissues (NALT,
cervical lymph nodes) were observed when B. pseudomallei
were inhaled within 12μm particles. This is similar to other
pathogens infective via the URT, including Yersinia pestis and
Bacillus anthracis (Thomas et al., 2009, 2010). URT pathology
resulting from B. pseudomallei infection has been observed in
US soldiers returning from Vietnam and patients in South-East
Asia presenting amongst other symptoms with severe pharyngitis
with tonsillar exudates, suppurative cervical lymphadenopathy,
and acute pansinusitis (Patterson et al., 1967; Lim et al., 2001).
This pathology is consistent with the murine infection produced
after the inhalation of 12μm aerosol particles. Despite signif-
icant clearance to the gastrointestinal tract, pathology was not
observed in infections caused by the inhalation of 1 or 12μm
particles. Infection via the gastrointestinal tract can occur in the
murine model, but only with high doses in the region of 108 cfu
(West et al., 2010). These doses far exceed the approximate 104 cfu
cleared to the stomach in this study.
Co-trimoxazole has previously been demonstrated to have
higher levels of efficacy (100%) compared to doxycycline (80%)
in the small particle inhalational murine model provided treat-
ment commenced prior to 48 h post-infection (Sivalingam et al.,
2008). In this study, irrespective of the site of deposition, inhala-
tional melioidosis was difficult to treat (Figure 6). One difference
may be the oral delivery method used for antibiotic dosing,
Sivalingam et al. (2008) used oral gavage and given the viscous
nature of the co-trimoxazole preparation (Septrin®) in partic-
ular, it is difficult to ascertain whether the mice swallowed the
entire dose via oral pipetting and at times a noticeable quantity
remained around the jowls; furthermore this study was con-
ducted for a greater period than 21 d post-infection to capture
relapse. Similar to the results of Sivalingam et al. (2008), Co-
trimoxazole was a significantly better treatment than doxycycline
for inhalational melioidosis. This is possibly due to the fact
that co-trimoxazole is bactericidal against B. pseudomallei whilst
doxycycline is bacteristatic as evidenced during in vitro time-
kill assays (Barnes pers. comm.). Hence, the potential to reduce
bacterial burden within extracellular locations prior to B. pseu-
domallei reaching areas where it may lie latent is greater with
co-trimoxazole. However, it must be noted that complete effi-
cacy was not observed in this study as relapse occurred once
treatment was terminated highlighting the intrinsic resistance of
this bacterium to antimicrobial therapy. This is probably due to
a number of reasons including bacterial resistance factors (i.e.,
efflux pumps) and lack of understanding mechanisms of latency
and pathological location (i.e., intracellular niche, abscessation,
neurological tissues). Further research to investigate aspects such
as latency and optimization of treatment regimes are currently
underway.
In addition to the respiratory route of infections, the olfactory
nervous systemmay warrant attention as a novel target for disease
prevention in B. pseudomallei. Certainly, little is known in this
region regarding host physical and immune strategies in prevent-
ing infection (Kalinke et al., 2011). It is interesting to speculate
whether the difficulties in treating inhalational infections within
animal models are a reflection of the multiple portals of entry
a pathogen may use to invade the body. Furthermore, intranasal
instillationmay not be themost appropriatemethod of evaluating
vaccine candidates and/or antimicrobial therapies for treatment
of respiratory infections due to the propensity to target pathogens
to not only the LRT, but also the URT (and indeed the GI tract)
with the relative concentrations at each site often undetermined.
This study indicates that in addition to inhalational melioidosis
initiating in the lungs, other sites of the respiratory tract should be
considered as portals of entry and that these may present further
complications to effective therapy.
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